-
Je něco špatně v tomto záznamu ?
Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms
Z. Baranyai, B. Biri-Kovács, M. Krátký, B. Szeder, ML. Debreczeni, J. Budai, B. Kovács, L. Horváth, E. Pári, Z. Németh, L. Cervenak, F. Zsila, E. Méhes, É. Kiss, J. Vinšová, S. Bősze
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- buněčné sféroidy účinky léků metabolismus MeSH
- endoteliální buňky pupečníkové žíly (lidské) MeSH
- glioblastom farmakoterapie metabolismus MeSH
- hematoencefalická bariéra metabolismus MeSH
- krysa rodu rattus MeSH
- lékové transportní systémy MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorové buňky kultivované MeSH
- nádory mozku farmakoterapie metabolismus MeSH
- neuropilin-1 metabolismus MeSH
- nosiče léků chemie farmakokinetika farmakologie MeSH
- oligopeptidy chemie farmakokinetika farmakologie MeSH
- penetrační peptidy chemie farmakokinetika farmakologie MeSH
- protinádorové látky chemie farmakokinetika farmakologie MeSH
- tuftsin analogy a deriváty farmakokinetika farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Most therapeutic agents used for treating brain malignancies face hindered transport through the blood-brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed peptide conjugates of conventional and experimental anticancer agents. SynB3 cell-penetrating peptide derivatives were applied that can cross the BBB. Tuftsin derivatives were used to target the neuropilin-1 transport system for selectivity and better tumor penetration. Moreover, SynB3-tuftsin tandem compounds were synthesized to combine the beneficial properties of these peptides. Most of the conjugates showed high and selective efficacy against glioblastoma cells. SynB3 and tandem derivatives demonstrated superior cellular internalization. The penetration profile of the conjugates was determined on a lipid monolayer and Transwell co-culture system with noncontact HUVEC-U87 monolayers as simple ex vivo and in vitro BBB models. Importantly, in 3D spheroids, daunomycin-peptide conjugates possessed a better tumor penetration ability than daunomycin. These conjugates are promising tools for the delivery systems with tunable features.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019003
- 003
- CZ-PrNML
- 005
- 20210830100545.0
- 007
- ta
- 008
- 210728s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.0c01399 $2 doi
- 035 __
- $a (PubMed)33719423
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Baranyai, Zsuzsa $u Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 245 10
- $a Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms / $c Z. Baranyai, B. Biri-Kovács, M. Krátký, B. Szeder, ML. Debreczeni, J. Budai, B. Kovács, L. Horváth, E. Pári, Z. Németh, L. Cervenak, F. Zsila, E. Méhes, É. Kiss, J. Vinšová, S. Bősze
- 520 9_
- $a Most therapeutic agents used for treating brain malignancies face hindered transport through the blood-brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed peptide conjugates of conventional and experimental anticancer agents. SynB3 cell-penetrating peptide derivatives were applied that can cross the BBB. Tuftsin derivatives were used to target the neuropilin-1 transport system for selectivity and better tumor penetration. Moreover, SynB3-tuftsin tandem compounds were synthesized to combine the beneficial properties of these peptides. Most of the conjugates showed high and selective efficacy against glioblastoma cells. SynB3 and tandem derivatives demonstrated superior cellular internalization. The penetration profile of the conjugates was determined on a lipid monolayer and Transwell co-culture system with noncontact HUVEC-U87 monolayers as simple ex vivo and in vitro BBB models. Importantly, in 3D spheroids, daunomycin-peptide conjugates possessed a better tumor penetration ability than daunomycin. These conjugates are promising tools for the delivery systems with tunable features.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x chemie $x farmakokinetika $x farmakologie $7 D000970
- 650 _2
- $a hematoencefalická bariéra $x metabolismus $7 D001812
- 650 _2
- $a nádory mozku $x farmakoterapie $x metabolismus $7 D001932
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a penetrační peptidy $x chemie $x farmakokinetika $x farmakologie $7 D057846
- 650 _2
- $a nosiče léků $x chemie $x farmakokinetika $x farmakologie $7 D004337
- 650 _2
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a glioblastom $x farmakoterapie $x metabolismus $7 D005909
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neuropilin-1 $x metabolismus $7 D039942
- 650 _2
- $a oligopeptidy $x chemie $x farmakokinetika $x farmakologie $7 D009842
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a buněčné sféroidy $x účinky léků $x metabolismus $7 D018874
- 650 _2
- $a tuftsin $x analogy a deriváty $x farmakokinetika $x farmakologie $7 D014405
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Biri-Kovács, Beáta $u Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary $u Institute of Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 700 1_
- $a Krátký, Martin $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
- 700 1_
- $a Szeder, Bálint $u Institute of Enzymology, Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary
- 700 1_
- $a Debreczeni, Márta L $u 3rd Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary
- 700 1_
- $a Budai, Johanna $u Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 700 1_
- $a Kovács, Bence $u Centre for Ecological Research, Institute of Ecology and Botany, Alkotmány u. 2-4, H-2163 Vácrátót, Hungary
- 700 1_
- $a Horváth, Lilla $u Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 700 1_
- $a Pári, Edit $u Laboratory of Interfaces and Nanostructures, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 700 1_
- $a Németh, Zsuzsanna $u 3rd Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary
- 700 1_
- $a Cervenak, László $u 3rd Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary
- 700 1_
- $a Zsila, Ferenc $u Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary
- 700 1_
- $a Méhes, Előd $u Department of Biological Physics, Institute of Physics, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 700 1_
- $a Kiss, Éva $u Laboratory of Interfaces and Nanostructures, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 700 1_
- $a Vinšová, Jarmila $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
- 700 1_
- $a Bősze, Szilvia $u Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 64, č. 6 (2021), s. 2982-3005
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33719423 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100545 $b ABA008
- 999 __
- $a ok $b bmc $g 1689934 $s 1139449
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 64 $c 6 $d 2982-3005 $e 20210315 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20210728